| Literature DB >> 25984740 |
Kimberly A Vonnahme1, Caleb O Lemley2, Joel S Caton3, Allison M Meyer4.
Abstract
As the demand for food increases with exponential growth in the world population, it is imperative that we understand how to make livestock production as efficient as possible in the face of decreasing available natural resources. Moreover, it is important that livestock are able to meet their metabolic demands and supply adequate nutrition to developing offspring both during pregnancy and lactation. Specific nutrient supplementation programs that are designed to offset deficiencies, enhance efficiency, and improve nutrient supply during pregnancy can alter tissue vascular responses, fetal growth, and postnatal offspring outcomes. This review outlines how vascularity in nutrient transferring tissues, namely the maternal gastrointestinal tract, the utero-placental tissue, and the mammary gland, respond to differing nutritional planes and other specific nutrient supplementation regimes.Entities:
Keywords: mammary gland; placenta; small intestine; uterine blood flow
Mesh:
Year: 2015 PMID: 25984740 PMCID: PMC4446764 DOI: 10.3390/nu7053497
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Changes in VEGF protein and placental mRNA as well as nitric oxide metabolite (NOx) and eNOS mRNA from mid- to late-gestation in cattle, sheep, and swine.
| In Circulation | mRNA in Fetal Placenta | mRNA in Maternal Placenta | |
|---|---|---|---|
| VEGF | |||
| Cow | Maternal: No change [ | 8% increase [ | 43% decrease [ |
| Sheep | Maternal: No change [ | 36% increase [ | 14% decrease [ |
| Pig | Fetal: 83% increase [ | 50% increase [ | 18% increase [ |
| Nitric Oxide | NOx | eNOS | eNOS |
| Cow | 210% increase [ | 29% increase [ | 49% increase [ |
| Sheep | 260% increase [ | 37% increase [ | 42% increase [ |
| Pig | ** | ** | ** |
*Not significant at p ≤ 0.05; ** Unknown.
Histological measurements to assess vascularity of nutrient transferring tissues.
| Measure | Calculation | Used to Assess |
|---|---|---|
| Capillary Area Density ( | total capillary area ÷ tissue area | blood flow |
| Capillary Surface Density ( | total vascular surface ÷ tissue area | nutrient exchange |
| Capillary Number Density ( | total number of vessels ÷ tissue area | vascular branching |
| Area Per Capillary ( | total capillary area ÷ number of vessels | capillary size |
| Total Vascularity | CAD × tissue mass | total vascular bed of tissue |
Vascularity and mass of the maternal small intestine in ovine and bovine models for investigating the interrelationships of nutrition and reproduction.
| Treatment | Stage | Impact on Vascularity * | Impact on Actual Mass | Impact on Production |
|---|---|---|---|---|
| Control (CON) | Mid gestation (Day 125) | NS 1 | NS | Fetal weight: NS |
| Control (CON) | Late gestation (Day 245) | NS | NS | Fetal weight: NS |
| Control (CON) | Mid gestation (Day 90) | CAD: RES greater than CON | CON > RES | Fetal weight: NS |
| Control (CON) | Late gestation (Day 130) | CAD: RES greater than CON | CON > RES | Fetal weight: CON greater than RES |
| Control (CON) | Late gestation (Day 135) | CAD 17% less, APC 16% less, and total vascularity 35% less in RES | 20% less in RES | Fetal weight 10% less in RES |
| Control (CON) | Late gestation (Day 132) | NS | NS | Fetal weight: NS |
| Control (CON) | Late gestation (Day 132) | NS | 17% less in CON-RES | Fetal weight 13% less in CON-RES |
| Control (CON) | Late gestation (Day 132) | NS | 13% less in RES-RES | Fetal weight 14% less in RES-RES |
| Control (CON) | Within 24 h post-partum | CSD 19% less in RES | NS | Birth weight 9% less in RES |
| Control (CON) | Early gestation (Day 50) | NS | 19% greater in HIGH | Fetal weight: NS |
| Control (CON) | Mid gestation (Day 90) | NS | 43% greater in HIGH | Fetal weight: NS |
| Control (CON) | Late gestation (Day 130) | NS | NS | Fetal weight 11% less in HIGH |
| Sheep—Gestation | ||||
| Control (CON) | Within 24 h post-partum | Total vascularity 38% greater in HIGH | 28% greater in HIGH | Birth weight: NS |
| Adequate Se (ASe; 0.3 ppm) vs. High Se (HSe; 3 ppm) | Late gestation (Day 135) | NS | 10% greater in HSe | Fetal weight 10% greater in HSe |
| Adequate Se (ASe; 0.3 ppm) | Late gestation (Day 132) | NS | NS | Fetal weight: NS |
| Adequate Se (ASe; 0.3 ppm) | Within 24 h post-partum | NS | 17% less in ASe | Birth weight: NS |
| Adequate Se (ASe; 0.14 ppm) | Late gestation (Day 134) | APC 33% less in HSe | NS | Fetal weight: NS |
| High-Se wheat | Late gestation (Day 134) | CND 25% greater and CSD 73% greater in selenate | NS | Fetal weight: NS |
| 3 ppm | Late gestation (Day 134) | NS | NS | Fetal weight: NS |
| Control (CON) | Early lactation (21 day) | CSD 5% greater in CON | NS (both increased post-partum) | Milk production 22% less in RES |
| Control (CON) | Early lactation (21 day) | Total vascularity 13% greater in HIGH | NS (both increased post-partum) | Milk production: NS |
| Adequate Se (ASe; 0.3 ppm) | Early lactation (21 day) | APC 23% greater in HSe | NS (both increased post-partum) | Milk production 10% greater for HSe |
* Vascularity measurements are included in Table 3. CAD = capillary area density; CSD = capillary surface density; CND = capillary number density; APC = area per capillary; 1 NS = not significant; 2 RES-CON = RES from Day 50 to 90 of gestation, CON from Day 90 to 132 of gestation; CON-RES = CON from Day 50 to 90 of gestation, RES from Day 90 to 132 of gestation; RES-RES = RES from Day 50 to 132 of gestation; 3 Fed to meet NRC requirements for lactation with adequate Se post-partum.
Expression of VEGF and NO system mRNAs in the small intestine of ewes.
| Treatment | Stage | Gene Expression 2 |
|---|---|---|
| Control (CON) | Late gestation (Day 135) | VEGF, FLT1, KDR: RES > CON |
| Control (CON) | Within 24 h post-partum | FLT1: RES > CON |
| Control (CON) | Within 24 h post-partum | VEGF, FLT1, and NOS3: HIGH > CON |
| Adequate Se (ASe; 0.3 ppm) | Late gestation (Day 135) | NS 3 |
| Adequate Se (ASe; 0.3 ppm) | Within 24 h post-partum | FLT1: ASe > HSe |
| Adequate Se (ASe; 0.14 ppm) | Late gestation (Day 134) | 4 KDR: ASe > HSe |
| High-Se wheat | Late gestation (Day 134) | 4 NS |
| 3 ppm | Late gestation (Day 134) | 4 VEGF: 15 ppm > 3 ppm |
| Control (CON) | Early lactation (21 day) | NS |
| Control (CON) | Early lactation (21 day) | NS |
| Adequate Se (ASe; 0.3 ppm) | Early lactation (21 day) | NS |
1 Fed to meet NRC requirements for lactation with adequate Se post-partum; 2 FLT1 = fms-related tyrosine kinase 1 (VEGF receptor 1), KDR = kinase insert domain receptor (VEGF receptor 2), GUCY1B3 = soluble guanylate cyclase (NO receptor); 3 NS = not significant; 4 NOS3 and GUCY1B3 were not measured.
Maternal and offspring measurements of branched-chain amino acid (BCAA).
| Dietary Treatment | Dependent Variable | Response |
|---|---|---|
| Fetal weight (Day 130) | Decreased 15% to 20% | |
| Placental weight (Day 130) | Similar | |
| Umbilical blood flow (Day 50–110) | Decreased 20% | |
| Decreased 20% | ||
| Uteroplacental nutrient flux (Day 130) | ||
| Uterine uptake of isoleucine | Decreased 42% | |
| Fetal uptake of isoleucine | Decreased 37% | |
| Uterine uptake of leucine | Similar | |
| Fetal uptake of leucine | Decreased 60% | |
| Uterine uptake of valine | Similar | |
| Fetal uptake of valine | Decreased 69% | |
| Fetal weight (Day 135) | Decreased 15% | |
| Maternal concentration of isoleucine | Decreased 19% | |
| Fetal concentration of isoleucine | Decreased 28% | |
| Maternal concentration of leucine | Decreased 41% | |
| Fetal concentration of leucine | Decreased 38% | |
| Maternal concentration of valine | Decreased 43% | |
| Fetal concentration of valine | Decreased 35% | |
| Fetal weight (Day 130) | Decreased 20% to 45% | |
| Placental weight (Day 130) | Similar | |
| Umbilical blood flow (Day 50–110) | Similar | |
| Increased 50% to 80% * | ||
| Maternal and Fetal BCAA (Day 130) | ||
| Maternal concentration of leucine | Similar | |
| Fetal concentration of leucine | Decreased 40% to 50% | |
| Maternal concentration of valine | Similar | |
| Fetal concentration of valine | Decreased 30% to 50% | |
| Maternal artery concentration of isoleucine | Similar | |
| Umbilical concentration of isoleucine | Decreased 19% | |
| Maternal artery concentration of leucine | Similar | |
| Umbilical concentration of leucine | Decreased 29% | |
| Maternal artery concentration of valine | Similar | |
| Umbilical concentration of valine | Decreased 20% | |
| Litter weights; litter sizes | Similar | |
| Maternal venous concentration of isoleucine | Decreased 32% | |
| Umbilical/fetal concentrations of isoleucine | Similar | |
| Maternal venous concentration of valine | Decreased 73% | |
| Umbilical/fetal concentrations of valine | Similar | |
| Maternal venous concentration of leucine | Decreased 21% | |
| Umbilical/fetal concentrations of leucine | Similar | |
| 6
| Newborn pup weights | Decreased 9% to 18% |
| Maternal concentration of isoleucine | Decreased 36% | |
| Newborn concentration of isoleucine | Decreased 59% | |
| Maternal concentration of leucine | Decreased 43% | |
| Newborn concentration of leucine | Decreased 60% | |
| Maternal concentration of valine | Decreased 52% | |
| Newborn concentration of valine | Decreased 68% |
* NS = not statistically different at p < 0.05.
Impacts of maternal diet during pregnancy on vascularity and production of the mammary gland in ewes.
| Treatment | Stage | Impact on Vascularity Compared to Control | Colostrum/Milk Production Compared to Control |
|---|---|---|---|
| Control | NS *, [ | Decreased 53%–70% [ | |
| Control | NS *, [ | Decreased 37%–58% [ | |
| Control | NS *, [ | Decreased 28% [ | |
| Control | NS *, [ | NS [ | |
| Control (0.3ppm) | birth | Increased 20%–25% [ | NS *, [ |
| Control (0.3ppm) | birth | NS *, [ | Increased 37% [ |
| Control (0.3ppm) | Lactation Day 20 | Increased 22% [ | Increased 10% [ |
* NS = not significant at p > 0.05.